| NDC Code | 0052-0603-02 |
|---|
| Package Description | 1 VIAL in 1 CARTON (0052-0603-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0052-0603-01) |
|---|
| Product NDC | 0052-0603 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Bcg Vaccine |
|---|
| Non-Proprietary Name | Bacillus Calmette-guerin Substrain Tice Live Antigen |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | PERCUTANEOUS |
|---|
| Start Marketing Date | 19890621 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA103050 |
|---|
| Manufacturer | Merck Sharp & Dohme LLC |
|---|
| Substance Name | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN |
|---|
| Strength | 50 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Actively Acquired Immunity [PE], BCG Vaccine [CS], Increased Immunologically Active Molecule Activity [PE], Increased Macrophage Proliferation [PE], Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC], Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC], Vaccines, Attenuated [CS] |
|---|